Novel Cisplatin-Magnetosome Complex Shows Enhanced Antitumor Activity via Hyperthermia

Author:

Jiménez-López M. Carmen1,Moreno-Maldonado Ana Carolina2,Martín-Morales Natividad1,O’Valle Francisco1,Ibarra M. Ricardo2,Goya Gerardo F.2,Molina Ignacio J.1

Affiliation:

1. University of Granada

2. CSIC-University of Zaragoza

Abstract

Abstract

There are many approaches to enhance the survival rate of cancer patients based on hyperthermia of tumor tissues, increasing their temperature above 41°C. These approaches use different energy sources to deliver the desired heat to the target region, including light, microwaves or radiofrequency electromagnetic fields. We have developed a new, magnetically responsive nanovector, composed by liposomes loaded with magnetic nanoparticles and cis-diamminedichloroplatinum (II) (CDDP), which is commonly known as Cisplatin. The resulting synthetic magnetosome (SM) is rapidly internalized by lung and pancreas tumor cell lines, stored in intracellular vesicles, and capable of inducing hyperthermia under magnetic fields. Additionally, it efficiently releases the cytotoxic drug upon an increase in temperature. The SM has no significant toxicity both in vitro and in vivo and, most importantly, enhances cell death by apoptosis after magnetic hyperthermia. This indicates that the intracellular release of low-dose CDDP increases the antitumor effect over CDDP-encapsulated liposomes and empty SM. Remarkably, mice bearing induced lung tumors, treated with CDDP-loaded nanovectors and subjected to an applied electromagnetic field, showed an improved survival rate over those treated with either soluble CDDP or hyperthermia alone. Therefore, our approach of magnetic hyperthermia plus CDDP- SM significantly enhances in vitro cell death and in vivo survival of treated animals.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3